TCF7L2 and cancer: In addition, cancers with alterations in RNF43, CTNNB1, and TCF7L2 displayed high rates of mutations in receptor tyrosine kinases, MMR-associated genes and DDR-associated genes, independently of the presence or absence of concomitant APC alterations.